AxoGen, Inc. (AXGN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AXGN Revenue Growth
Revenue Breakdown
AXGN's revenue distribution by segment and geography
By Geography
AXGN Revenue Analysis (2014–2025)
As of May 8, 2026, AxoGen, Inc. (AXGN) generated trailing twelve-month (TTM) revenue of $238.1 million, reflecting exceptional growth of +26.6% year-over-year. The most recent quarter (Q1 2026) recorded $61.5 million in revenue, up 2.6% sequentially.
Looking at the longer-term picture, AXGN's 5-year compound annual growth rate (CAGR) stands at +14.9%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $225.2 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including TELA (+12.2% YoY), NVCR (+8.5% YoY), and XTNT (+16.9% YoY), AXGN has outperformed the peer group in terms of revenue growth. Compare AXGN vs TELA →
AXGN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AXGNCurrent | $238M | +26.6% | +14.9% | -3.5% | |
 TELA | $69M | +12.2% | +35.0% | -49.2% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 XTNT | $117M | +16.9% | +12.6% | -10.3% | |
 MDXG | $419M | +10.5% | +11.0% | 15.3% | |
 ANIK | $113M | +23.2% | -2.9% | -9.8% |
AXGN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $225.2M | +20.2% | $167.4M | 74.3% | $-7,849,000 | -3.5% |
| 2024 | $187.3M | +17.8% | $142.0M | 75.8% | $-3,287,000 | -1.8% |
| 2023 | $159.0M | +14.7% | $121.9M | 76.6% | $-21,462,000 | -13.5% |
| 2022 | $138.6M | +8.8% | $108.8M | 78.5% | $-29,707,000 | -21.4% |
| 2021 | $127.4M | +13.4% | $104.4M | 82.0% | $-25,416,000 | -20.0% |
| 2020 | $112.3M | +5.2% | $90.7M | 80.8% | $-23,182,000 | -20.6% |
| 2019 | $106.7M | +27.1% | $89.4M | 83.7% | $-31,406,000 | -29.4% |
| 2018 | $83.9M | +38.9% | $71.0M | 84.6% | $-20,500,000 | -24.4% |
| 2017 | $60.4M | +47.0% | $51.1M | 84.6% | $-7,951,286 | -13.2% |
| 2016 | $41.1M | +50.4% | $34.6M | 84.3% | $-8,129,862 | -19.8% |
See AXGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AXGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AXGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAXGN — Frequently Asked Questions
Quick answers to the most common questions about buying AXGN stock.
Is AXGN's revenue growth accelerating or slowing?
AXGN revenue is accelerating at +26.6% year-over-year, exceeding the 5-year CAGR of +14.9%. TTM revenue reached $238M. Growth momentum has increased versus prior periods.
What is AXGN's long-term revenue growth rate?
AxoGen, Inc.'s 5-year revenue CAGR of +14.9% reflects the sustained expansion pattern. Current YoY growth of +26.6% is above this long-term average.
How is AXGN's revenue distributed by segment?
AXGN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.